Európai Unió - izlandi - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatíð - osteoporosis; osteoporosis, postmenopausal - kalsíumsterastasis - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

bluefish pharmaceuticals ab - eplerenonum inn - filmuhúðuð tafla - 25 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - eplerenonum inn - filmuhúðuð tafla - 50 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

laboratoires besins international - testosteronum inn - hlaup til notkunar um húð - 50 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - rabeprazolum natríum - magasýruþolin tafla - 20 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

evolan pharma ab - alimemazinum tartrat - hart hylki - 20 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - sildenafilum cítrat - filmuhúðuð tafla - 100 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - finasteridum inn - filmuhúðuð tafla - 5 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 50 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 37,5 mg